Nuvation Bio to Report Third Quarter 2026 Financial Results and Provide Business Update on November 4, 2026
NEW YORK, Oct. 21, 2026 /PRNewswire/ -- Nuvation Bio Inc. ("Nuvation Bio") (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced it will host a conference call and webcast on Wednesday, November 4, 2026, at 4:30...
Covered in this story
Call it yourself
No calls on $NUVB yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Nuvation Bio Inc Class a →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.